# Séverine Vermeire

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/severine-vermeire/

## Facts

| Field | Value |
| --- | --- |
| Citations | 113,546 |
| Field | Inflammatory Bowel Disease |
| h-index | 165 |
| i10-index | 784 |
| Last Known Institution | Universitair Ziekenhuis Leuven |
| OpenAlex ID | https://openalex.org/A5019474609 |
| ORCID iD | 0000-0001-9942-3019 |
| Works | 2,372 |

## Researcher papers

Showing 12 of 26.

- [Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology](https://scholariq.org/papers/toward-an-integrated-clinical-molecular-and-serological-classification-of/)
- [Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease](https://scholariq.org/papers/genome-wide-association-defines-more-than-30-distinct-susceptibility-loci-for/)
- [Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci](https://scholariq.org/papers/genome-wide-meta-analysis-increases-to-71-the-number-of-confirmed-crohn-s/)
- [Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease](https://scholariq.org/papers/influence-of-immunogenicity-on-the-long-term-efficacy-of-infliximab-in-crohn-s/)
- [A decrease of the butyrate-producing species <i>Roseburia hominis</i> and <i>Faecalibacterium prausnitzii</i> defines dysbiosis in patients with ulcerative colitis](https://scholariq.org/papers/a-decrease-of-the-butyrate-producing-species-i-roseburia-hominis-i-and-i/)
- [Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease](https://scholariq.org/papers/ustekinumab-as-induction-and-maintenance-therapy-for-crohn-s-disease/)
- [Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis](https://scholariq.org/papers/tofacitinib-as-induction-and-maintenance-therapy-for-ulcerative-colitis/)
- [Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management](https://scholariq.org/papers/second-european-evidence-based-consensus-on-the-diagnosis-and-management-of/)
- [Quantitative microbiome profiling links gut community variation to microbial load](https://scholariq.org/papers/quantitative-microbiome-profiling-links-gut-community-variation-to-microbial/)
- [The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations](https://scholariq.org/papers/the-second-european-evidence-based-consensus-on-the-diagnosis-and-management-of/)
- [VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death](https://scholariq.org/papers/vegf-is-a-modifier-of-amyotrophic-lateral-sclerosis-in-mice-and-humans-and/)
- [Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD](https://scholariq.org/papers/primary-sclerosing-cholangitis-is-characterised-by-intestinal-dysbiosis/)

## Researcher topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)
- [Immunodeficiency and Autoimmune Disorders](https://scholariq.org/topics/immunodeficiency-and-autoimmune-disorders/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)
- [Eosinophilic Esophagitis](https://scholariq.org/topics/eosinophilic-esophagitis/)

## Researcher university

- [Universitair Ziekenhuis Leuven](https://scholariq.org/institutions/universitair-ziekenhuis-leuven/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.